STOCK TITAN

[Form 4] FIREFLY NEUROSCIENCE, INC. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Firefly Neuroscience (AIFF): A reporting group led by Windsor Private Capital disclosed open‑market sales of common stock under Rule 144. On 10/20/2025 they sold 33,500 shares at $2.457; on 10/21/2025 they sold 19,222 shares at $2.4004; and on 10/22/2025 they sold 78,031 shares at $2.0727.

Following these transactions, the group states it is no longer a beneficial owner of more than 10% of the company’s securities. After the final sale, 1,236,773 shares were beneficially owned indirectly, held through Windsor, per the filing footnotes.

Firefly Neuroscience (AIFF): un gruppo di segnalazione guidato da Windsor Private Capital ha comunicato vendite sul mercato aperto di azioni ordinarie ai sensi della Rule 144. Il 20/10/2025 hanno venduto 33.500 azioni a 2,457 USD; il 21/10/2025 hanno venduto 19.222 azioni a 2,4004 USD; e il 22/10/2025 hanno venduto 78.031 azioni a 2,0727 USD. Dopo queste operazioni, il gruppo afferma di non detenere più di una partecipazione superiore al 10% delle azioni della società. Dopo l’ultima vendita, 1.236.773 azioni erano detenute indirettamente per tramite Windsor, secondo le note di deposito.

Firefly Neuroscience (AIFF): un grupo de informes dirigido por Windsor Private Capital divulgó ventas en el mercado abierto de acciones ordinarias conforme a la Regla 144. El 20/10/2025 vendieron 33.500 acciones a 2,457 USD; el 21/10/2025 vendieron 19.222 acciones a 2,4004 USD; y el 22/10/2025 vendieron 78.031 acciones a 2,0727 USD. Tras estas operaciones, el grupo afirma que ya no es titular beneficioso de más del 10% de las acciones de la empresa. Después de la venta final, 1.236.773 acciones eran posesión beneficiosa indirecta, mantenidas a través de Windsor, según las notas del registro.

Firefly Neuroscience (AIFF): Windsor Private Capital이 이끄는 보고 그룹이 Rule 144에 따른 일반 주식의 공개 시장 매도를 공시했습니다. 2025년 10월 20일에는 33,500주를 2.457달러에 매도했고; 2025년 10월 21일에는 19,222주를 2.4004달러에 매도했으며; 2025년 10월 22일에는 78,031주를 2.0727달러에 매도했습니다. 이러한 거래 후 그룹은 더 이상 회사 주식의 10%를 초과하는 유익한 소유자가 아니라고 밝힙니다. 최종 매도 후 Windsor를 통해 간접 보유된 유익한 소유 주식은 1,236,773주로 기록에 따라 보유되었습니다.

Firefly Neuroscience (AIFF) : un groupe de reporting dirigé par Windsor Private Capital a divulgué des ventes sur le marché libre d’actions ordinaires en vertu de la règle 144. Le 20/10/2025, ils ont vendu 33 500 actions à 2,457 USD ; le 21/10/2025, ils ont vendu 19 222 actions à 2,4004 USD ; et le 22/10/2025, ils ont vendu 78 031 actions à 2,0727 USD. Suite à ces transactions, le groupe déclare ne plus être bénéficiaire de plus de 10 % des titres de la société. Après la vente finale, 1 236 773 actions étaient détenues indirectement par Windsor, selon les notes du dossier.

Firefly Neuroscience (AIFF): Eine Meldegruppe unter Führung von Windsor Private Capital gab Offenmarktverkäufe von Stammaktien gemäß Regel 144 bekannt. Am 20.10.2025 verkauften sie 33.500 Aktien zu 2,457 USD; am 21.10.2025 verkauften sie 19.222 Aktien zu 2,4004 USD; und am 22.10.2025 verkauften sie 78.031 Aktien zu 2,0727 USD. Nach diesen Transaktionen erklärt die Gruppe, dass sie nicht mehr als 10 % der Wertpapiere des Unternehmens besitzt. Nach dem letzten Verkauf wurden 1.236.773 Aktien indirekt im Besitz von Windsor gemäß den Einreichungs-Footnotes gehalten.

Firefly Neuroscience (AIFF): مجموعة تقارير تقودها Windsor Private Capital كشفت عن مبيعات في السوق المفتوحة للأسهم العادية وفق Rule 144. في 20/10/2025 باعوا 33,500 سهم بسعر 2.457 دولار؛ في 21/10/2025 باعوا 19,222 سهمًا بسعر 2.4004 دولار؛ وفي 22/10/2025 باعوا 78,031 سهمًا بسعر 2.0727 دولار. عقب هذه المعاملات، تنص المجموعة أنها لم تعد مالكة مستفيدة لأكثر من 10% من أوراق الشركة. بعد البيع النهائي، كانت 1,236,773 سهمًا مملوكة بشكل غير مباشر عبر Windsor، وفق ملاحظات الإيداع.

Firefly Neuroscience (AIFF): 由 Windsor Private Capital 领导的报告小组披露了根据 Rule 144 的普通股公开市场销售。2025年10月20日,他们以每股2.457美元卖出33,500股;2025年10月21日以每股2.4004美元卖出19,222股;2025年10月22日以每股2.0727美元卖出78,031股。完成这些交易后,该集团表示不再是公司证券超过10%有益所有者。最后一次出售后,1,236,773股通过 Windsor 间接持有,按申报脚注所示。

Positive
  • None.
Negative
  • None.

Insights

Large holder sold shares over three days and fell below 10%.

The filing lists three Rule 144 sales of AIFF common stock: 33,500 shares at $2.457 on 10/20/2025, 19,222 shares at $2.4004 on 10/21/2025, and 78,031 shares at $2.0727 on 10/22/2025. These are open‑market broker‑dealer transactions.

Footnotes state the reporting persons are now below the 10% beneficial ownership threshold and characterize this as an exit filing. The reported holdings are indirect via Windsor, with 1,236,773 shares beneficially owned following the last transaction.

Changes in large‑holder status can affect float dynamics, but actual impact depends on future trading by holders and broader market conditions.

Firefly Neuroscience (AIFF): un gruppo di segnalazione guidato da Windsor Private Capital ha comunicato vendite sul mercato aperto di azioni ordinarie ai sensi della Rule 144. Il 20/10/2025 hanno venduto 33.500 azioni a 2,457 USD; il 21/10/2025 hanno venduto 19.222 azioni a 2,4004 USD; e il 22/10/2025 hanno venduto 78.031 azioni a 2,0727 USD. Dopo queste operazioni, il gruppo afferma di non detenere più di una partecipazione superiore al 10% delle azioni della società. Dopo l’ultima vendita, 1.236.773 azioni erano detenute indirettamente per tramite Windsor, secondo le note di deposito.

Firefly Neuroscience (AIFF): un grupo de informes dirigido por Windsor Private Capital divulgó ventas en el mercado abierto de acciones ordinarias conforme a la Regla 144. El 20/10/2025 vendieron 33.500 acciones a 2,457 USD; el 21/10/2025 vendieron 19.222 acciones a 2,4004 USD; y el 22/10/2025 vendieron 78.031 acciones a 2,0727 USD. Tras estas operaciones, el grupo afirma que ya no es titular beneficioso de más del 10% de las acciones de la empresa. Después de la venta final, 1.236.773 acciones eran posesión beneficiosa indirecta, mantenidas a través de Windsor, según las notas del registro.

Firefly Neuroscience (AIFF): Windsor Private Capital이 이끄는 보고 그룹이 Rule 144에 따른 일반 주식의 공개 시장 매도를 공시했습니다. 2025년 10월 20일에는 33,500주를 2.457달러에 매도했고; 2025년 10월 21일에는 19,222주를 2.4004달러에 매도했으며; 2025년 10월 22일에는 78,031주를 2.0727달러에 매도했습니다. 이러한 거래 후 그룹은 더 이상 회사 주식의 10%를 초과하는 유익한 소유자가 아니라고 밝힙니다. 최종 매도 후 Windsor를 통해 간접 보유된 유익한 소유 주식은 1,236,773주로 기록에 따라 보유되었습니다.

Firefly Neuroscience (AIFF) : un groupe de reporting dirigé par Windsor Private Capital a divulgué des ventes sur le marché libre d’actions ordinaires en vertu de la règle 144. Le 20/10/2025, ils ont vendu 33 500 actions à 2,457 USD ; le 21/10/2025, ils ont vendu 19 222 actions à 2,4004 USD ; et le 22/10/2025, ils ont vendu 78 031 actions à 2,0727 USD. Suite à ces transactions, le groupe déclare ne plus être bénéficiaire de plus de 10 % des titres de la société. Après la vente finale, 1 236 773 actions étaient détenues indirectement par Windsor, selon les notes du dossier.

Firefly Neuroscience (AIFF): Eine Meldegruppe unter Führung von Windsor Private Capital gab Offenmarktverkäufe von Stammaktien gemäß Regel 144 bekannt. Am 20.10.2025 verkauften sie 33.500 Aktien zu 2,457 USD; am 21.10.2025 verkauften sie 19.222 Aktien zu 2,4004 USD; und am 22.10.2025 verkauften sie 78.031 Aktien zu 2,0727 USD. Nach diesen Transaktionen erklärt die Gruppe, dass sie nicht mehr als 10 % der Wertpapiere des Unternehmens besitzt. Nach dem letzten Verkauf wurden 1.236.773 Aktien indirekt im Besitz von Windsor gemäß den Einreichungs-Footnotes gehalten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Windsor Private Capital LP

(Last) (First) (Middle)
22 ST. CLAIR AVENUE EAST
SUITE 202

(Street)
TORONTO A6 M4T 2S3

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
FIREFLY NEUROSCIENCE, INC. [ AIFF ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock(1) 10/20/2025 S(2) 33,500 D $2.457 1,334,026 I See footnote(3)
Common Stock(1) 10/21/2025 S(2) 19,222 D $2.4004 1,314,804 I See footnote(3)
Common Stock(1) 10/22/2025 S(2) 78,031 D $2.0727 1,236,773 I See footnote(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
Windsor Private Capital LP

(Last) (First) (Middle)
22 ST. CLAIR AVENUE EAST
SUITE 202

(Street)
TORONTO A6 M4T 2S3

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
WPC Management Services Inc.

(Last) (First) (Middle)
22 ST. CLAIR AVENUE EAST
SUITE 202

(Street)
TORONTO A6 M4T 2S3

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
WPC GP I Inc.

(Last) (First) (Middle)
22 ST. CLAIR AVENUE EAST
SUITE 202

(Street)
TORONTO A6 M4T 2S3

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Kupinsky Jordan

(Last) (First) (Middle)
395 BROOKE AVENUE

(Street)
TORONTO A6 M5M 2L5

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
HJRK Holdings Inc.

(Last) (First) (Middle)
395 BROOKE AVENUE

(Street)
TORONTO A6 M5M 2L5

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
HJR Kupinsky 2013 Family Trust

(Last) (First) (Middle)
395 BROOKE AVENUE

(Street)
TORONTO A6 M5M 2L5

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Marcello Rocco

(Last) (First) (Middle)
22 ST. CLAIR AVENUE EAST
SUITE 202

(Street)
TORONTO A6 M4T 2S3

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Cundari John

(Last) (First) (Middle)
22 ST. CLAIR AVENUE EAST
SUITE 202

(Street)
TORONTO A6 M4T 2S3

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. This Form 4 is filed jointly by Windsor Private Capital LP ("Windsor"), WPC Management Services Inc. ("WPC Management Services"), WPC GP I Inc. ("WPC"), Jordan Kupinsky ("Mr. Kupinsky"), HJRK Holdings Inc. ("HJRK"), HJR Kupinsky 2013 Family Trust ("HJRK Trust"), Rocco Marcello ("Mr. Marcello") and John Cundari ("Mr. Cundari", and collectively, the "Reporting Persons"). The Reporting Persons are members of a "group" that beneficially owns more than 10% of the shares of common stock of Firefly Neurosciences, Inc. (the "Issuer").
2. These transactions occurred pursuant to broker-dealer sales conducted in accordance with Rule 144 under the Securities Act of 1933, as amended. Following these transactions, the Reporting Persons are no longer beneficial owners of more than 10% of the Issuer's securities and as such, this filing represents an exit filing for the Reporting Persons.
3. The reported securities are held directly by Windsor. Mr. Marcello is Founder, Chairman and Chief Executive Officer of Windsor. Mr. Cundari is President of Windsor. Mr. Kupinsky is Managing Partner of Windsor. WPC is the general partner of Windsor and WPC Management Services is the sole shareholder of WPC. Mr. Marcello, Mr. Cundari and Mr. Kupinsky are the directors of WPC and WPC Management Services. WPC Management Services, WPC, Mr. Kupinsky, Mr. Marcello and Mr. Cundari may be deemed to beneficially own the reported securities. WPC Management Services, WPC, Mr. Kupinsky, Mr. Marcello and Mr. Cundari disclaim beneficial ownership of the securities held directly by Windsor except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that any of WPC Management Services, WPC, Mr. Kupinsky, Mr. Marcello or Mr. Cundari is a beneficial owner of such securities for purposes of Section 16 or any other purpose.
Windsor Private Capital LP, by its General Partner, WPC GP I Inc., /s/ John Cundari, Partner 10/22/2025
WPC Management Services Inc., /s/ John Cundari, Partner 10/22/2025
WPC GP I Inc., /s/ John Cundari, Partner 10/22/2025
/s/ Jordan Kupinsky 10/22/2025
HJRK Holdings Inc., /s/ Jordan Kupinsky, President and Director 10/22/2025
HJR Kupinsky 2013 Family Trust, by its Trustee, Jordan Kupinsky, /s/ Jordan Kupinsky 10/22/2025
/s/ Rocco Marcello 10/22/2025
/s/ John Cundari 10/22/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did AIFF report?

A reporting group sold common stock in three Rule 144 transactions on 10/20/2025, 10/21/2025, and 10/22/2025.

How many AIFF shares were sold on each date?

33,500 shares at $2.457 on 10/20/2025; 19,222 shares at $2.4004 on 10/21/2025; 78,031 shares at $2.0727 on 10/22/2025.

Is the reporting group still a 10% owner of AIFF?

No. The filing states they are no longer beneficial owners of more than 10% of the issuer’s securities.

How many AIFF shares were beneficially owned after the final transaction?

1,236,773 shares were beneficially owned indirectly following the 10/22/2025 sale.

Who holds the reported AIFF shares indirectly?

The filing notes the shares are held directly by Windsor Private Capital LP, with related entities and individuals as described in the footnotes.

Under what rule were the AIFF share sales executed?

The sales were conducted in accordance with Rule 144 under the Securities Act of 1933.
Firefly Neuroscience Inc.

NASDAQ:AIFF

AIFF Rankings

AIFF Latest News

AIFF Latest SEC Filings

AIFF Stock Data

31.60M
8.71M
38.52%
10.85%
13.28%
Software - Application
Services-prepackaged Software
Link
United States
KENMORE